US03168L1052 - Common Stock
AMNEAL PHARMACEUTICALS INC
NASDAQ:AMRX (3/28/2024, 2:15:35 PM)
6.14
+0.02 (+0.33%)
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. The company is headquartered in Bridgewater, New Jersey and currently employs 7,600 full-time employees. The company went IPO on 2009-11-18. The firm is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The firm's Specialty segment’s portfolio includes central nervous system disorders (Parkinson’s disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Company’s AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.
AMNEAL PHARMACEUTICALS INC
400 Crossing Boulevard, 3rd Floor
Bridgewater NEW JERSEY 08807
P: 19089473120
CEO: Chirag Patel
Employees: 7600
Website: https://amneal.com/
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news!
Amneal Pharmaceuticals reports Q4 earnings, beating earnings per share estimates but missing revenue expectations.
Here you can normally see the latest stock twits on AMRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: